View in EDS HTML Full Text PDF Full Text

Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.

Saved in:
Bibliographic Details
Title: Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.
Authors: Tamura R; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Fujioka M; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Morimoto Y; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Ohara K; Department of Pathology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Kosugi K; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Oishi Y; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Sato M; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Ueda R; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Fujiwara H; Department of Radiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Hikichi T; OncoTherapy Science, Inc., 3-2-1, Sakado, Takatsu-ku, Kawasaki City, Kanagawa, 213-0012, Japan., Noji S; Division of Cellular Signaling Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Oishi N; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Ogawa K; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Kawakami Y; Division of Cellular Signaling Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Ohira T; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Yoshida K; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Toda M; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. todam@keio.jp.
Source: Nature communications [Nat Commun] 2020 Apr 21; Vol. 11 (1), pp. 2028. Date of Electronic Publication: 2020 Apr 21.
Publication Type: Journal Article; Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32317644
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tamura+R%22">Tamura R</searchLink>; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Fujioka+M%22">Fujioka M</searchLink>; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Morimoto+Y%22">Morimoto Y</searchLink>; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Ohara+K%22">Ohara K</searchLink>; Department of Pathology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Kosugi+K%22">Kosugi K</searchLink>; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Oishi+Y%22">Oishi Y</searchLink>; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+M%22">Sato M</searchLink>; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Ueda+R%22">Ueda R</searchLink>; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Fujiwara+H%22">Fujiwara H</searchLink>; Department of Radiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Hikichi+T%22">Hikichi T</searchLink>; OncoTherapy Science, Inc., 3-2-1, Sakado, Takatsu-ku, Kawasaki City, Kanagawa, 213-0012, Japan.<br /><searchLink fieldCode="AU" term="%22Noji+S%22">Noji S</searchLink>; Division of Cellular Signaling Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Oishi+N%22">Oishi N</searchLink>; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Ogawa+K%22">Ogawa K</searchLink>; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Kawakami+Y%22">Kawakami Y</searchLink>; Division of Cellular Signaling Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Ohira+T%22">Ohira T</searchLink>; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+K%22">Yoshida K</searchLink>; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.<br /><searchLink fieldCode="AU" term="%22Toda+M%22">Toda M</searchLink>; Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. todam@keio.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2020 Apr 21; Vol. 11 (1), pp. 2028. <i>Date of Electronic Publication: </i>2020 Apr 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32317644
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-020-16007-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2028
    Titles:
      – TitleFull: Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tamura R
      – PersonEntity:
          Name:
            NameFull: Fujioka M
      – PersonEntity:
          Name:
            NameFull: Morimoto Y
      – PersonEntity:
          Name:
            NameFull: Ohara K
      – PersonEntity:
          Name:
            NameFull: Kosugi K
      – PersonEntity:
          Name:
            NameFull: Oishi Y
      – PersonEntity:
          Name:
            NameFull: Sato M
      – PersonEntity:
          Name:
            NameFull: Ueda R
      – PersonEntity:
          Name:
            NameFull: Fujiwara H
      – PersonEntity:
          Name:
            NameFull: Hikichi T
      – PersonEntity:
          Name:
            NameFull: Noji S
      – PersonEntity:
          Name:
            NameFull: Oishi N
      – PersonEntity:
          Name:
            NameFull: Ogawa K
      – PersonEntity:
          Name:
            NameFull: Kawakami Y
      – PersonEntity:
          Name:
            NameFull: Ohira T
      – PersonEntity:
          Name:
            NameFull: Yoshida K
      – PersonEntity:
          Name:
            NameFull: Toda M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 04
              Text: 2020 Apr 21
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1